PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system: role in pathogenesis of migraine? by unknown
BioMed CentralBMC Pharmacology
ssOpen AccePoster presentation
PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular 
pain signalling system: role in pathogenesis of migraine?
Lars S Kruse*1,2, Morten Møller3, Maiken Tibæk2, Steen Gammeltoft1, 
Jes Olesen2 and Christina Kruuse2
Address: 1Department of Clinical Biochemistry, Glostrup Hospital, DK-2600 Glostrup, Denmark, 2Danish Headache Center, Department of 
Neurology, Glostrup Hospital, DK-2600 Glostrup, Denmark and 3Department of Neuroscience and Pharmacology, University of Copenhagen, 
DK-2200, Denmark
Email: Lars S Kruse* - lakr@glo.regionh.dk
* Corresponding author    
Background
Activation of the trigeminovascular pain signalling sys-
tem, which includes cerebral arteries, meninges, trigemi-
nal ganglion, and brain stem, may be involved in
migraine. Furthermore, stimulation of cyclic nucleotide
(cAMP and cGMP) production as well as inhibition of
phosphodiesterases (PDEs) induces headache and
migraine [1-4]. The aim is to study the expression of the
most recently discovered PDE subtypes (9A, 10A and
11A) in cerebral arteries, the dura mater, and the trigemi-
nal ganglion and nucleus. This may give a clue to a role in
pathogenesis of migraine.
Methods
The amount of mRNA and protein in the middle cerebral
artery, basilar artery, dura, trigeminal ganglion, and cau-
dal trigeminal nucleus of male Sprague-Dawley rats were
investigated using real-time PCR, Western blot, and
immunohistochemistry, and compared to two peripheral
arteries: aorta and mesenteric artery, as well as neocortex
and cerebellum.
Results
Real-time PCR of mRNA and Western blotting showed
that PDE9A, PDE10A and PDE11A are expressed in com-
ponents of the rat trigeminovascular pain signalling sys-
tem including middle cerebral artery, basilar artery, dura
mater, trigeminal ganglion and trigeminal nucleus (Fig.
1). Aorta and mesenteric artery as well as cerebral cortex
and cerebellum also showed expression of PDE9A,
PDE10A and PDE11A. Immunohistochemistry showed
that PDE9A, PDE10A and PDE11A are localised in the
cytosol of nerve cell bodies of the trigeminal ganglion
(Fig. 2).
Conclusion
We here present, for the first time the expression of the
three most recently discovered PDEs in the trigeminovas-
cular pain signalling system. The functional implications
are yet unknown, but their localisation indicates that
PDE9A, PDE10A and PDE11A may have a role in patho-
genesis of migraine.
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Immunohistochemical analysis of PDE10A in the trigeminal ganglion and duraFigure 2
Immunohistochemical analysis of PDE10A in the trigeminal ganglion and dura. A-C: PDE10A-immunoreactive neuronal cell 
bodies in the trigeminal ganglion (arrows) at various magnifications. D: PDE10A-immunoreactive nerve cells in the cortex and 
cells in the dura (arrows). Bar = 100 μm.
Western blotting of PDE9A, PDE10A and PDE11A proteinsFigure 1
Western blotting of PDE9A, PDE10A and PDE11A proteins. Expression is shown in middle cerebral artery (MCA), basilar 
artery (Basil.), dura, trigeminal ganglion (TGG) and trigeminal nucleus (TGN). Positive controls were included: PDE9A in cere-
bellum, PDE10A in rat brain and PDE11A in prostate. β-actin expression was used to determine the protein loading on the gel.
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